Emerging Use of BPC-157 in Orthopaedic Sports Medicine: A Systematic Review "Even though it is not approved by the US Food and Drug Administration and is banned in some sports, BPC-157 is still being used
Preclinical research suggests that increasing NAD may have therapeutic potential for neurodegenerative disorders by helping repair damage, reducing neuroinflammation, and improving learning and memory
Long-acting formulations, multi-target drugs, and oral drugs are currently the main areas of research in the GLP-1 space
We also included washout periods of up to 3 years after antibiotic treatment to correct for protopathic biases caused by reverse causality
Polyphenols, dietary sources and bioavailability
Damaged mitochondria leak excess electrons, causing an explosion of ROS that completely overwhelms the cell's antioxidant capacity